H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
2017 · Scientific Reports · 66 citations
https://doi.org/10.1038/s41598-017-07617-7
M
Melissa Bellini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
491
Citations
13
h-index
14
i10-index
Melissa Bellini is an academic researcher from Guglielmo da Saliceto Hospital. The author has contributed to research in topics: Genomic variations and chromosomal abnormalities & Genetics and Neurodevelopmental Disorders & Congenital heart defects research. The author has an h-index of 13, co-authored 30 publications.
ORCID: 0009-0006-8399-139XPapers by this author
worksCo-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
2020 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-020-68205-w
Deep phenotyping of the neuroimaging and skeletal features in KBG syndrome: a study of 53 patients and review of the literature
2023 · Journal of Medical Genetics · 13 citations
https://doi.org/10.1136/jmg-2023-109141
An uncommon neuroradiological finding of hippocampal malrotation in childhood onset schizophrenia and 22q11.2 Deletion Syndrome: a case report and a brief review of the literature
2024 · European Child & Adolescent Psychiatry · 2 citations
https://doi.org/10.1007/s00787-024-02569-6
PEG10 loss of function causes Silver-Russell syndrome: a familial case with paternal deletion
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-32983-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat